ALEXA ALTER: Open Payments
NPI 1437797578 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 46 payments from 16 companies in 2025. Trend: 2023 $4,447 · 2024 $2,074 · 2025 $1,009
Food & beverage: $909Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $192 |
| Incyte Corporation | 6 | $174 |
| Janssen Biotech, Inc. | 7 | $164 |
| UCB, Inc. | 1 | $125 |
| GENZYME CORPORATION | 1 | $120 |
| Botanix SB Inc | 3 | $48 |
| Arcutis Biotherapeutics, Inc. | 2 | $34 |
| LNHC, Inc | 2 | $32 |
| Amgen Inc. | 1 | $19 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $18 |
Products named: OPZELURA, TREMFYA, SKYRIZI, Bimzelx, DUPIXENT, RINVOQ, SOFDRA, Zoryve.
Industry payments across NJ — which companies pay providers there.
